PRESS RELEASE
News
-
-
-
PRESS RELEASE
Sekur Private Data Ltd. Announces Closing of its Non-Brokered Private Placement - Insiders Participate in Offering
Sekur Private Data Ltd. announces successful completion of Private Placement offering $1,612,757.50 gross proceeds. Company officers and directors participated in the placement, purchasing 450,000 Units. Net proceeds to fund marketing and working capital -
-
PRESS RELEASE
Leclanché SA: Invitation to the Upcoming Annual General Meeting of Shareholders to be Held on 5 August 2025 at 10:00 am Swiss TimeInvitation to the Upcoming Annual General Meeting of Shar
Leclanché SA convenes its Annual General Meeting on 5 August 2025 at 10:00 am to propose debt-to-equity conversion and financial restructuring measures -
PRESS RELEASE
Leclanché SA: Leclanché Publishes its Annual Report 2024 and Non-financial ESG Report
Leclanché SA publishes its Annual Report 2024 and Non-financial ESG Report, revealing CHF 18.4 million consolidated income, reduced net loss and strengthened balance sheet. Signs CHF 18 million funding deal and progresses in strategic investments -
-
-
-
PRESS RELEASE
Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
Protagonist Therapeutics announces development candidate PN-477, a triple agonist peptide, targeting GLP-1, GIP, GCG receptors for obesity treatment. IND-enabling studies in progress, Phase I initiation expected in 2Q26
